These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7776900)

  • 1. Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data.
    Massion AO; Teas J; Hebert JR; Wertheimer MD; Kabat-Zinn J
    Med Hypotheses; 1995 Jan; 44(1):39-46. PubMed ID: 7776900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients.
    Carlson LE; Speca M; Patel KD; Goodey E
    Psychoneuroendocrinology; 2004 May; 29(4):448-74. PubMed ID: 14749092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.
    Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Grioni S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):729-37. PubMed ID: 20200429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and breast cancer: a prospective study.
    Travis RC; Allen DS; Fentiman IS; Key TJ
    J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size.
    Bartsch C; Bartsch H; Karenovics A; Franz H; Peiker G; Mecke D
    J Pineal Res; 1997 Sep; 23(2):53-8. PubMed ID: 9392442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary melatonin levels and breast cancer risk.
    Schernhammer ES; Hankinson SE
    J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease.
    Girotti L; Lago M; Ianovsky O; Carbajales J; Elizari MV; Brusco LI; Cardinali DP
    J Pineal Res; 2000 Oct; 29(3):138-42. PubMed ID: 11034110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intense blue light therapy during the night-time does not suppress the rhythmic melatonin biosynthesis in a young boy.
    Stebelova K; Kosnacova J; Zeman M
    Endocr Regul; 2017 Jan; 51(1):31-34. PubMed ID: 28222021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual changes in 6-sulphatoxymelatonin excretion in man.
    Bojkowski CJ; Arendt J
    Acta Endocrinol (Copenh); 1988 Apr; 117(4):470-6. PubMed ID: 3389039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meditation and prostate cancer: integrating a mind/body intervention with traditional therapies.
    Coker KH
    Semin Urol Oncol; 1999 May; 17(2):111-8. PubMed ID: 10332925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache.
    Leone M; Lucini V; D'Amico D; Grazzi L; Moschiano F; Fraschini F; Bussone G
    Cephalalgia; 1998 Dec; 18(10):664-7. PubMed ID: 9950622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-sulphatoxymelatonin production in breast cancer patients.
    Skene DJ; Bojkowski CJ; Currie JE; Wright J; Boulter PS; Arendt J
    J Pineal Res; 1990; 8(3):269-76. PubMed ID: 2380908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 6-sulfatoxymelatonin and mammographic density in Japanese women.
    Nagata C; Matsubara T; Hara T; Fujita H; Nagao Y; Yamamoto S; Shibuya C; Kashiki Y; Shimizu H
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2509-12. PubMed ID: 18006946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study to examine the effects of a mindfulness-based stress-reduction and relaxation program on levels of stress hormones, physical functioning, and submaximal exercise responses.
    Robert McComb JJ; Tacon A; Randolph P; Caldera Y
    J Altern Complement Med; 2004 Oct; 10(5):819-27. PubMed ID: 15650471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary 6-sulphatoxymelatonin, an index of pineal function in the rat.
    Brown GM; Bar-Or A; Grossi D; Kashur S; Johannson E; Yie SM
    J Pineal Res; 1991 Apr; 10(3):141-7. PubMed ID: 1880710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morning urinary assessment of nocturnal melatonin secretion in older women.
    Cook MR; Graham C; Kavet R; Stevens RG; Davis S; Kheifets L
    J Pineal Res; 2000 Jan; 28(1):41-7. PubMed ID: 10626600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of light pulses on 6-sulphatoxymelatonin rhythms in rats.
    Kennaway DJ; Rowe SA
    J Pineal Res; 1994 Mar; 16(2):65-72. PubMed ID: 8014825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation of melatonin, light exposure, and diurnal preference in day and night shift workers of both sexes.
    Papantoniou K; Pozo OJ; Espinosa A; Marcos J; Castaño-Vinyals G; Basagaña X; Ribas FC; Mirabent J; Martín J; Carenys G; Martín CR; Middleton B; Skene DJ; Kogevinas M
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1176-86. PubMed ID: 24812038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients.
    Carlson LE; Speca M; Faris P; Patel KD
    Brain Behav Immun; 2007 Nov; 21(8):1038-49. PubMed ID: 17521871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function.
    Baskett JJ; Cockrem JF; Antunovich TA
    J Pineal Res; 1998 Jan; 24(1):58-61. PubMed ID: 9468119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.